Efficacy and Safety of PARPi to Treat Pancreatic Cancer
NCT02511223
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
OTHER_GOV
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
OLAPARIB
Sponsor
Sheba Medical Center